CAE Inc
Change company Symbol lookup
Select an option...
CAE CAE Inc
YMAB Y-mAbs Therapeutics Inc
VINE Fresh Vine Wine Inc
BURU NUBURU Inc
AMPX Amprius Technologies Inc
CKPT Checkpoint Therapeutics Inc
IR Ingersoll Rand Inc
AVID Avid Technology Inc
VTSI VirTra Inc
UHAL U-Haul Holding Co
Go

Industrials : Aerospace & Defense | Mid Cap Growth
Based in Canada
Company profile

CAE Inc. is a Canada-based technology company. The Company operates through three segments: Civil Aviation, Defense and Security, and Healthcare. The Civil Aviation training segment provides comprehensive training solutions for flight, cabin, maintenance and ground personnel in commercial, business and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training and crew sourcing services, as well as end-to-end digitally enabled crew management, training operations solutions and optimization software. The defense and Security segment provides training and simulation pure play focusing on ensuring mission readiness by integrating systems and solutions across all five domains for government organizations responsible for public safety. Healthcare segment provides healthcare students and clinical professionals innovative, integrated and virtual education and training solutions, including interventional and imaging simulations and curricular.

Closing Price
$22.63
Day's Change
0.30 (1.34%)
Bid
--
Ask
--
B/A Size
--
Day's High
22.67
Day's Low
22.27
Volume
(Heavy Day)
Volume:
233,906

10-day average volume:
173,158
233,906

Agilent Authorizes $2 Billion Share Repurchase Program

4:30 pm ET January 9, 2023 (BusinessWire) Print

Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company's common stock.

"Agilent is committed to balanced capital deployment that drives growth and helps deliver strong returns for shareholders," said Bob McMahon, Agilent chief financial officer. "This share repurchase program is a key element of that strategy."

The new program will begin March 1. Upon commencement, the new repurchase program replaces Agilent's existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs.

The number of shares to be repurchased and the timing of any repurchases will depend on factors such as the stock price, economic and market conditions, and corporate and regulatory requirements. The stock repurchase program may be suspended or discontinued at any time.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, statements regarding the company's share repurchase programs. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent's customers' businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; the adverse impacts of and risks posed by the COVID-19 pandemic; and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the fiscal quarter ended October 31, 2022. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230109005593/en/

SOURCE: Agilent Technologies Inc.

Media Contact: 
Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Investor Contact: 
Parmeet Ahuja
+1 408-345-8948
parmeet_ahuja@agilent.com
comtex tracking

COMTEX_422384593/1006/2023-01-09T16:30:06

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.